Find out who works
by our side every day
Commercially exploit your assets providing your models and virtual patients to companies and researchers all over the world through our platform
Research Centers & Universities
70+ universities worldwide already cooperate with us to transform the best models into innovative digital solutions
We are actively involved in regulatory activities and we are part of collaborations with the FDA and EMA
Software Solution Providers
We work with qualified partners to offer you AI tools within integrated solutions through our patented platform
InSilicoTrials has signed a 5-years research agreement with the FDA for dissemination of regulatory models.
We are leader of the Good Simulation Practices’ Task Force within the Avicenna Alliance working with 100+ Researchers, Companies and regulators like the FDA.
We are members of the working group for “Percorsi di adozione della Medicina In Silico in Italia” by the Italian Superior Health Council – Ministry of Health (Consiglio Superiore di Sanità- Ministero della Salute).
InSilicoTrials is also a member of EMA’ s Consultative Working Group for Cloud Security.
Our models are the result of the long and hard work of many researchers. We participate in many internationally funded projects to commercialize models and we acquire the most relevant solutions to make them available to the healthcare industry.